A strategic framework for patient support program impact measurement

Patient support programs (PSPs) are now among pharma’s largest commercial investments, yet many organizations still measure them through activity metrics that show effort, not impact.

This white paper outlines a practical framework for proving and improving the value of PSPs by connecting services to patient outcomes, cost-to-serve efficiency and resource allocation decisions. It explores what patient services leaders should measure, why PSP measurement is uniquely complex and how advances in data infrastructure, causal analytics and AI are making more rigorous impact measurement possible.

Through real-world examples, the paper shows how companies can identify which services work best, for which patient segments and at what cadence—then use those insights to optimize program design, defend investment and improve patient experience in a compliant way.

Download the paper